Seattle, WA, United States of America

Mark M Wurfel

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Bloodworks Northwest, Fred Hutchinson Cancer Center, University of Washington. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mark M Wurfel. Retrieved from https://idiyas.com/inventor/mark-m-wurfel-yftcf69q

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Mark M Wurfel: Innovations in Immunotherapy

Introduction

Mark M Wurfel is a notable inventor based in Seattle, Washington. He has made significant contributions to the field of immunotherapy, particularly in the identification and management of adverse effects associated with treatment. With one patent to his name, his work revolves around enhancing patient safety and treatment efficacy.

Latest Patents

Wurfel's patent, titled "Biomarkers and Uses Thereof for Selecting Immunotherapy Intervention," is a groundbreaking advance in medical science. This patent provides crucial biomarkers and methodologies for identifying subjects at risk of developing cytokine release syndrome (CRS) and neurotoxicity following adoptive immunotherapy. The invention aims to guide preemptive interventions, integrating biomarkers such as temperature, cytokine levels, and endothelial activation factors like angiopoietin 2 and von Willebrand factor (vWF). These biomarkers can be measured before and after chemotherapy and immunotherapy, allowing for timely therapeutic modifications to mitigate potential adverse events.

Career Highlights

Mark M Wurfel has worked with leading institutions that focus on cancer treatment and research, including the Fred Hutchinson Cancer Center and the University of Washington. His experience in these reputable organizations has equipped him with a deep understanding of immunotherapy processes and patient care strategies.

Collaborations

Throughout his career, Wurfel has collaborated with esteemed colleagues such as W. Conrad Liles and Cameron J. Turtle. These partnerships have fostered a collaborative environment that has been essential to his research and patent developments.

Conclusion

Mark M Wurfel's contributions to immunotherapy reflect his dedication to improving patient outcomes. His innovative work in identifying biomarkers for adverse effects of treatment represents a significant step forward in the field, paving the way for safer and more effective immunotherapy interventions. As the medical landscape continues to evolve, Wurfel’s invention stands as a testament to the importance of innovation in addressing critical healthcare challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…